Anthony K. Blair

Anthony K. Blair has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Zomedica Corp. and Navidea Biopharmaceuticals, Inc. Over a trading history stretching from 27 May 2011 to 21 May 2025, the count stands at 7 filings.

In open-market terms, that means 6 purchases worth €81k on one side and 1 sale worth €185k on the other. Netting one side against the other leaves €103k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 3 purchases and no sales.

A typical purchase (the median) is worth €15k. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -16.4%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 21 May 2025, reports an open-market purchase of €2,813 in Zomedica Corp. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.